X0306 4 2012-12-17 0 0001070698 Raptor Pharmaceutical Corp RPTP 0001243489 SAGER ERICH C/O RAPTOR PHARMACEUTICAL CORP. 9 COMMERCIAL BLVD., SUITE 200 NOVATO CA 94949 1 0 0 0 Common Stock 2012-12-17 4 M 0 9187 2.57 A 121185 D Common Stock 2012-12-17 4 M 0 1797 2.02 A 122982 D Common Stock 2012-12-17 4 S 0 10984 5.43 D 111998 D Common Stock 2012-12-17 4 S 0 3924 5.35 D 108074 D Stock options (right to buy) 2.57 2012-12-17 4 M 0 3359 0 D 2006-11-26 2016-05-25 Common Stock 3359 503156 D Stock options (right to buy) 2.57 2012-12-17 4 M 0 5828 0 D 2007-12-14 2017-06-13 Common Stock 5828 497328 D Stock options (right to buy) 2.02 2012-12-17 4 M 0 1797 0 D 2010-09-09 2020-03-08 Common Stock 1797 495531 D Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 12, 2012. Original option grant vests 6/36ths on November 26, 2006 and 1/36th per month thereafter. Original option grants vests 6/48ths on December 14, 2007 and 1/48th per month thereafter. Original option grants vests 6/48ths on September 9, 2010 and 1/48th per month thereafter. This transaction was executed in multiple trades at prices ranging from $5.34 to $5.50. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $5.32 to $5.47. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. /s/ Kim R. Tsuchimoto, Vice President-Finance, Raptor Pharmaceutical Corp., Attorney-in-fact 2012-12-18